Abstract MYCBP2 -associated neurodevelopmental disorder is an autosomal dominant genetic disorder, previously described with de novo variants. We present the case of a two-generation review of a proband with a maternally inherited heterozygous pathogenic variant in MYCBP2 , c.4409dup (p.Leu1470Phefs*7). Neuropsychology assessment indicated developmental delays with proband’s scores falling well below age-level expectations, while proband’s mother demonstrated generally intact cognition with evidence of subtle executive inefficiency. Assessment of parental genotype and phenotype can help to anticipate child’s developmental trajectory, especially in genetic disorders associated with highly variable expressivity. However information gaps on familial impact of inherited neurodevelopmental disorders across generations remain.
Pham et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: